SavedAdd your journal

Journals / Journal of Human Rhythm / 2017 / Cilt: 3 - Sayı: 1

Serum Asymmetric Dimethyl Arginine Level is Associated with the Pain Intensity in Primary Dysmenorrhea

Nermin AKDEMİR
Fatma Behice CİNEMRE
Mehmet Süha BOSTANCI
Hakan CİNEMRE
Orhan ÜNAL
Selçuk ÖZDEN
Arif Serhan CEVRİOĞLU
Zübeyde KAÇAL
Ramazan AKDEMİR
Pages
36–41
Publication Date
2017-03-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Menstrual pain intensity is correlated with the serum ADMA levels as assessed by VAS pain score in PD patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Aim of this study is the investigation of the association between Serum Asymmetric Dimethyl Arginine (ADMA) levels and menstrual pain intensity as assessed by Visual Analogue Scale in primary dysmenorrhea patients.
📊
Key Findings & Data:PD pain was graded using Visual Analogue Scale (VAS), as mild, moderate and severe.
💡
Conclusion & Impact:Conclusion: Menstrual pain intensity is correlated with the serum ADMA levels as assessed by VAS pain score in PD patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Asymmetric Dimethyl Arginine · Pain Intensity · Primary Dysmenorrhea

Abstract

Background: Aim of this study is the investigation of the association between Serum Asymmetric Dimethyl Arginine (ADMA) levels and menstrual pain intensity as assessed by Visual Analogue Scale in primary dysmenorrhea patients. Methods: Eighty-nine young women with primary dysmenorrhea (PD) were selected as study group. PD pain was graded using Visual Analogue Scale (VAS), as mild, moderate and severe. Serum ADMA levels was measured in all subjects. Results: Mean age of study population was 21.08±2.21 and mean VAS score was 5.9101±2.18. Serum ADMA levels were 35.2(24) in mild, 54.0(28.7) in moderate and 56.5(32.8) in severe pain groups, (P= 0.029 and P=0.001, respectively). Mean ADMA levels difference were -18.8, p=0.046 in mild to moderate; -2.52, p=0. 945 in moderate to severe and 21.32 p=0.048 in severe to mild pain groups. Conclusion: Menstrual pain intensity is correlated with the serum ADMA levels as assessed by VAS pain score in PD patients

🔖

Cite This Article

AKDEMİR, N., CİNEMRE, F. B., BOSTANCI, M. S., CİNEMRE, H., ÜNAL, O., ÖZDEN, S., CEVRİOĞLU, A. S., KAÇAL, Z., AKDEMİR, R. (2017). Serum Asymmetric Dimethyl Arginine Level is Associated with the Pain Intensity in Primary Dysmenorrhea. Journal of Human Rhythm, Cilt: 3 - Sayı: 1, 36–41. https://ajindex.com/articles/835830

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Akdemir N, Cinemre H, Bilir C, Akin O, Akdemir R. Increased serum asymmetric dimethyl arginine levels in primary dysmenorrhea. Gynecol Obstet Invest. 2010
  2. 69(3): 153-6. 2. Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, et.al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005
  3. 27(12): 1117-46. 3. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015
  4. 21(6): 762-78. 4. Haman JO. Pain threshold in dysmenorrhea. Am J Obstet Gynecol 1944
  5. 686–69 5. Savvidou MD, Hingorani AD, Tsikas D, Frölich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003
  6. 361(9368): 1511-7. 6. Charitidou C, Farmakiotis D, Zournatzi V, Pidonia I, Pegiou T, Karamanis N, et.al. The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome. Atherosclerosis. 2008
  7. 196(2):958-65. 7. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986
  8. 27(1): 117-26. 8. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983
  9. Paice J, Cohen F. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs 1997
  10. Jones KR, Fink R, Hutt E, Vojir C, Pepper GA, Scott-Cawiezell J, Mellis BK. Measuring pain intensity in nursing home residents. J Pain Symptom Manage. 2005
  11. 30(6): 519-27. Blackwell S. The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine. Ann Clin Biochem. 2010
  12. 47(Pt 1):17-28. 12. Akdemir N, Cinemre FB, Bostancı MS, Cinemre H, Ünal O, Ozden S, et.al. The correlation of serum asymmetric dimethylarginine and anti-Müllerian hormone in primary dysmenorrhea. Kaohsiung J Med Sci. 2016
  13. 32(8):414-9. 13. Akdemir N, Akhin O. Increased serum asymmetric dimethylarginine levels in hyperemesis gravidarum. Arch Gynecol Obstet. 2012
  14. 285(2):339-42. 14. Sari I, Kebapcilar L, Alacacioglu A, Bilgir O, Yildiz Y, Taylan A, et.al. Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis. Intern Med. 2009
  15. 48(16):1363-8. 15. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plas